We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
International Business Machines Corp | NYSE:IBM | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
1.60 | 0.97% | 166.29 | 166.61 | 164.92 | 165.00 | 3,386,067 | 01:00:00 |
By Laura Cooper and Cara Lombardo
International Business Machines Corp. is exploring a potential sale of its IBM Watson Health business, according to people familiar with the matter, as the technology giant's new chief executive moves to streamline the company and become more competitive in cloud computing.
IBM is studying alternatives for the unit that could include a sale to a private-equity firm or industry player or a merger with a blank-check company, the people said. The unit, which employs artificial intelligence to help hospitals, insurers and drugmakers manage their data, has roughly $1 billion in annual revenue and isn't currently profitable, the people said.
Its brands include Merge Healthcare, which analyzes mammograms and MRIs; Phytel, which assists with patient communications; and Truven Health Analytics, which analyzes complex healthcare data.
It isn't clear how much the business might fetch in a sale, and there may not be one.
Write to Laura Cooper at laura.cooper@wsj.com and Cara Lombardo at cara.lombardo@wsj.com
(END) Dow Jones Newswires
February 18, 2021 20:21 ET (01:21 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year International Business M... Chart |
1 Month International Business M... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions